Sandoz

Sandoz

Arzneimittelherstellung

Basel, Basel-Stadt 924.765 Follower:innen

Info

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars.

Website
https://www.sandoz.com
Branche
Arzneimittelherstellung
Größe
10.001 Beschäftigte
Hauptsitz
Basel, Basel-Stadt
Art
Kapitalgesellschaft (AG, GmbH, UG etc.)
Spezialgebiete
Generics, Biosimilars und Over the counter medicines

Orte

Beschäftigte von Sandoz

Updates

  • Unternehmensseite von Sandoz anzeigen, Grafik

    924.765 Follower:innen

    This week at Sandoz, we discussed how we can continue to build upon our culture to create a truly diverse and inclusive environment for the LGBTQI community and allies. Employees around the world joined our global Pride webcast, ‘Leading by Example to Spark Progress’. We heard from colleagues on how they are engaging in LGBTQI initiatives, and some of our senior leaders shared their personal experiences and recommendations. By coming together to learn more, listen, and grow in our understanding of the challenges faced by the LGBTQI community, we can create meaningful change. Check out this video from around the globe to see how colorful Sandoz looked in June. And while Pride month is coming to a close, it doesn’t stop there. We are committed to embracing the spirit of Pride and LGBTQI inclusion in all that we do, every day, from equipping our employees with clear guidance in our Transgender Identity and Allyship Guides, to providing safe spaces to share and learn from experiences. #SandozPride #PrideMonth

  • Unternehmensseite von Sandoz anzeigen, Grafik

    924.765 Follower:innen

    We recently brought together 31 patient advocacy leaders in Munich to discuss crucial issues impacting access to medicines. With a focus on biosimilars and generics, our goal was to identify key policy issues, address knowledge gaps, and drive expanded access through collaboration. Many thanks to the co-chairs of the Forum Zorana Maravic and Daneen Sekoni and all the participants for the meaningful conversations that transcended borders. Stay tuned for updates on the actionable steps that will emerge from these important discussions. Together, we can make a difference! 💙 #MakingAccessHappen #Biosimilars #Generics #Collaboration #GlobalHealthcare

  • Unternehmensseite von Sandoz anzeigen, Grafik

    924.765 Follower:innen

    Throughout the year at Sandoz we celebrate what makes us unique, and Pride month is an opportunity to celebrate the LGBTQI community and recognize the strength, resilience and progress that comes from standing together in unity. By fostering a sense of community among our LGBTQI employees and allies, we can empower everyone to be their authentic selves, to leverage our diverse perspectives to make an impact on our patient mission and collectively create positive change. Together, we can amplify voices, advocate for equality, and build a more inclusive society. Thanks to Paul Walz for sharing his experience of working at Sandoz. Click to learn more: https://lnkd.in/dbxSxAKP #SandozPride #PrideMonth #Pride #SandozLife

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Sandoz anzeigen, Grafik

    924.765 Follower:innen

    We support stronger healthcare systems by providing affordable medicines. In 2023, our products alone delivered over USD 18 billion in savings to US and EU healthcare systems by providing high quality generic and biosimilar medicines to patients.   As the global population keeps growing and ageing, placing an ever-increasing financial strain on healthcare systems, we are democratizing biologic medicines by increasing their availability and affordability, and by educating healthcare professionals on their use. Today, we already market 10 successful biosimilars with an additional 24 in the pipeline.   #Generics #Biosimilars #PatientAccess

  • Unternehmensseite von Sandoz anzeigen, Grafik

    924.765 Follower:innen

    According to the WHO, more than 600,000 people die every year as a result of HIV/AIDS because they didn’t know they had HIV or because they started treatment too late. Latin America is among the regions most affected, where annual numbers of new HIV cases have increased by 8% from 2010 to 2022. We recognize the importance of prevention, education, and accurate information about HIV. In September 2023, we launched the ‘PrEPárate contra el VIH’ campaign to help raise awareness of HIV in Mexico. Through in-person events and social media, the local community in Mexico and beyond can access reliable information from healthcare experts in a simple and digestible way. Learn more: https://lnkd.in/gcc9CKiQ #SandozPride #HIVPrEP #PrideMonth

  • Unternehmensseite von Sandoz anzeigen, Grafik

    924.765 Follower:innen

    Through our presence in more than 100 markets we already provide over 800 million patient treatments per year, freeing up resources for healthcare systems and generating a positive social impact estimated at USD 400 billion. To continue providing equal access to quality-assured generic and biosimilar medicines to more patients worldwide, collaboration with organizations like IGBA - International Generic and Biosimilar medicines Association is key.

  • Unternehmensseite von Sandoz anzeigen, Grafik

    924.765 Follower:innen

    Rebecca Guntern, Region Europe President at Sandoz, is back from Medicines for Europe Annual Conference, celebrating their remarkable 30th anniversary of advocating for better healthcare policies in Europe. She reflects on the insights gained from the conference, where industry leaders gathered to explore the past three decades of progress and project their visions for the next 20-30 years.

    Profil von Rebecca Guntern anzeigen, Grafik

    President Region Europe Sandoz

    We recently commemorated 30 years of industry progress at the Medicines for Europe Annual Conference in Dublin. Under the leadership of Medicines of Europe, significant strides have been taken to bridge the access gap in healthcare over the last three decades. Adrian van den Hoven and the team have organised another great conference for us to look back and move forward. A special thank you to our panelists - Pierluigi Antonelli, Elisabeth Stampa, Stephan Eder, Steffen Saltofte and Markus Sieger for their valuable contributions to the engaging discussion. Coming together once again was a great opportunity to align on the future trajectory of our industry. While foreseeing the future is complex, I firmly believe that off-patent medicines will continue to play a pivotal role in the healthcare system for another 30 years.

    Looking back, moving forward: how we can shape a bright future for healthcare in Europe

    Looking back, moving forward: how we can shape a bright future for healthcare in Europe

    Rebecca Guntern auf LinkedIn

  • Sandoz hat dies direkt geteilt

    Generic and biosimilar medicines account for 70% of the medicines dispensed in Europe, so it’s critical that the policies and legal frameworks governing the pharmaceutical industry put patients and healthcare systems first to ensure access to affordable medicines at the earliest possible date. The Medicines for Europe team put on another excellent edition of its Legal Affairs Conference in Ireland earlier this week and Karen Gallagher of Pinsent Masons did a great job moderating our General Counsel panel on how a reshaping world is reshaping our industry. Thank you to fellow panelists Agnieszka Deeg-Tyburska, Mark Ferguson, and Barbara Majcen for their excellent insights. We all have a role to play in making early access happen and Sandoz is looking forward to working with policymakers, regulators, reference medicines companies, and other stakeholders to address the challenges we are all currently facing.

    Making access happen: How to ensure a level legal playing field for critical medicines

    Making access happen: How to ensure a level legal playing field for critical medicines

    Ingrid Sollerer auf LinkedIn

  • Sandoz hat dies direkt geteilt

    Profil von Dr. Tamara Scheidl (🏳️‍⚧️) anzeigen, Grafik

    Leading Global Quality Services in Sandoz / Support of inclusive workplaces for the LGBTQI community as Co-Lead Global LGBTQI ERG and Lead Austrian LGBTQI ERG / Enjoying life with a toddler

    Last year during Transgender Awareness Week 🏳️⚧️, I revealed my true identity as transgender woman to my colleagues at Sandoz Österreich and globally. This year’s Pride Month, June 2024, marks the first Pride am celebrating as my authentic self, as Tamara. 🏳️⚧️ The last months have been the most joyful in my life, finally being myself. Sandoz has declared 2024 as Year of the Allyship. Looking into the increasing threats to members of the LGBTQI community, allieship is key. Everyone of you can be an Ally. But what makes a good Ally? For me: 🌈 A good Ally is using the privilege of their voice supporting the community even if there is no member of the LGBTQI community in the room. 🌈 A good Ally is here for me to talk and listen to me when needed and is open to learn. 🌈 A good Ally is fighting together with me against discrimination, inequality and fear. I have found my biggest Ally already in my wife. I love you! ❤️ 💙 🌈 Allyship does not end at the office door and is not limited to professional life. 🌈 Allyship is needed in private life as well, speaking up against the increasing injustice the LGBTQI community 🏳️🌈and recently specifically the Transgender Community 🏳️⚧️is politically facing. Let’s all be Allies and build a more inclusive society for us and for our loved ones and our children. 🏳️⚧️🏳️🌈🌈Happy Pride Month 2024! 🌈🏳️🌈🏳️⚧️ As lead of the Pride Community of Belonging (CoB) at Sandoz Österreich I am very proud that we support the #PerlenPride in Kufstein in October as well as the #InnsbruckPride in July - looking forward seeing many of you there!

    • Tamara standing with Transgender Pride Flag

Verbundene Seiten

Ähnliche Seiten

Finanzierung

Sandoz Insgesamt 1 Finanzierungsrunde

Letzte Runde

Fremdkapital nach Börsengang

2.947.398.393,00 $

Weitere Informationen auf Crunchbase